SEC Contract Filing

Filing Date: 2015-03-02

Document Content:
<DOCUMENT>
<TYPE>EX-10.60
<SEQUENCE>3
<FILENAME>exhibit10_60.htm
<DESCRIPTION>EXHIBIT 10.60
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: Thomson Reuters Accelus
 Document created using Disclosure Solutions PROFILE 3.2.1.0
 Copyright 1995 - 2015 Thomson Reuters Accelus. All rights reserved.-->
</head>
<body bgcolor="#ffffff" text="#000000" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">
<div>
<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: small-caps; font-weight: bold; font-style: normal; text-align: left;">
<hr noshade="noshade" style="height: 4px; color: #000000; text-align: center; margin-left: auto; background-color: #000000; margin-right: auto;">
</div>

<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: normal; font-weight: normal; font-style: normal; text-align: left;">
<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: small-caps; font-weight: bold; text-align: left;">Confidential</div>

<div><br>
</div>

<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: small-caps; text-align: right;">CONFIDENTIAL TREATMENT REQUESTED</div>

<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: small-caps; text-align: right;">UNDER 17 C.F.R &#167;&#167; 200.80(B)4, AND 240.24B-2</div>

<div><br>
</div>

<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: small-caps; font-weight: bold; text-align: right;">Exhibit 10.60</div>

<div><br>
</div>

<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: small-caps; text-align: center;">Research Collaboration, Option and License Agreement</div>

<div><br>
</div>

<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: small-caps; text-align: center;">Between</div>

<div><br>
</div>

<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: small-caps; text-align: center;">Isis Pharmaceuticals, Inc.</div>

<div><br>
</div>

<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: small-caps; text-align: center;">And</div>

<div><br>
</div>

<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: small-caps; text-align: center;">Janssen Biotech Inc.</div>

<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div>

<div id="DSPFPageBreakArea" style="margin-bottom: 10pt; clear: both; margin-top: 10pt;">
<hr id="DSPFPageBreak" noshade="noshade" style="border-left-width: 0px; height: 2px; border-right-width: 0px; width: 100%; border-bottom-width: 0px; page-break-after: always; color: #000000; clear: both; margin: 4px 0px; border-top-width: 0px; background-color: #000000;">
</div>

<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: small-caps; font-weight: bold; text-align: left;">Confidential</div>
</div>

<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: small-caps; font-weight: bold; font-style: normal; text-align: left;">&#160;</div>

<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: normal; font-weight: normal; font-style: normal; text-align: left;">
<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; text-align: center;">RESEARCH COLLABORATION, OPTION AND LICENSE AGREEMENT</div>

<div><br>
</div>

<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">This RESEARCH COLLABORATION, OPTION AND LICENSE AGREEMENT (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Agreement</font>&#8221;) is entered into as of the 22<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">nd</sup> day of December, 2014 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Effective Date</font>&#8221;), by and between <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: small-caps; font-weight: bold;">Isis Pharmaceuticals, Inc.</font>, a Delaware corporation, having its principal place of business at 2855 Gazelle Court, Carlsbad, CA 92010 (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Isis</font>&#8221;), and<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: small-caps; font-weight: bold;"> Janssen Biotech Inc.</font>, a Pennsylvania company, with principal offices located at 800/850 Ridgeview Road, Horsham, PA 19044 (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><u>JBI</u></font>&#8221;) JBI and Isis each may be referred to herein individually as a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Party</font>&#8221; or collectively as the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; font-style: italic;">Parties</font>.&#8221; Capitalized terms used in this Agreement, whether used in the singular or the plural, have the meaning set forth in <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: small-caps;"><u>Appendix</u></font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u> 1</u></font>. All attached appendices and schedules are a part of this Agreement.</div>

<div><br>
</div>

<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; text-align: center;">RECITALS</div>

<div><br>
</div>

<div s